A degenerative disease causing breakdown of hip joint cartilage, pain, and stiffness
Managing Expectations & Practical Guidance for Patients As orforglipron moves toward approval and commercial availability, patients, providers, and the broader public will need realistic expectations about what this drug can and cannot do
USA 108 , 80308035 (2011)
Spectrochim Acta A Mol Biomol Spectrosc
The judge overseeing the group GLP-1 lawsuit issued a memorandum on which experts testimonies will be allowed to be used in the case and what test people need to provide as evidence
GLP-1 medications carry important warnings and contraindications, including a boxed warning for thyroid C-cell tumors in rodents (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2)